Carroll Financial Associates, Inc. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2018$2,0000.0%8500.0%0.00%
Q2 2018$2,000
+100.0%
8500.0%0.00%
Q1 2018$1,000
-66.7%
8500.0%0.00%
Q4 2017$3,000
-40.0%
8500.0%0.00%
-100.0%
Q3 2017$5,000
+25.0%
8500.0%0.00%
Q2 2017$4,000
-20.0%
8500.0%0.00%
-100.0%
Q1 2017$5,0000.0%8500.0%0.00%0.0%
Q4 2016$5,000
+25.0%
8500.0%0.00%0.0%
Q3 2016$4,000
+33.3%
8500.0%0.00%0.0%
Q2 2016$3,0000.0%8500.0%0.00%0.0%
Q1 2016$3,0008500.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders